deltatrials
Completed OBSERVATIONAL NCT04900259

The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations

Sponsor: Ankara Training and Research Hospital

Interventions COVID-19 pandemic
Updated 6 times since 2021 Last updated: Sep 29, 2021 Started: Jul 1, 2021 Primary completion: Aug 1, 2021 Completion: Aug 15, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04900259, this observational or N/A phase trial focuses on Bladder Cancer and Covid19 and remains completed. Sponsored by Ankara Training and Research Hospital, it has been updated 6 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Nov 2021 · 2 months · monthly snapshot~Nov 2021 – ~Jul 2024 · 32 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 8 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Nov 2021 — Jul 2024 [monthly]

    Completed

    Status: Not Yet RecruitingCompleted

  5. Sep 2021 — Nov 2021 [monthly]

    Not Yet Recruiting

Show 1 earlier version
  1. Jun 2021 — Sep 2021 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ankara Training and Research Hospital
Data source: Ankara Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations